Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald C DeConti

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|April 10, 2012
Chemotherapy of squamous cell carcinoma of the skinRonald C DeConti
Seminars in Oncology|April 10, 2012
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinomaSreekanth Donepudi, Ronald C DeConti, Wolfram E Samlowski
Seminars in Oncology|April 10, 2012
Introduction: Advanced cutaneous malignanciesL Frank Glass, Ronald C DeConti, Vernon K Sondak
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Survival after surgical resection of isolated pulmonary metastases from malignant melanomaStephanie Andrews, Lary Robinson, Alan Cantor, et al.
Cancer|January 20, 2011
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, et al.
Head & Neck|March 14, 2014
Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neckTawee Tanvetyanon, Tapan Padhya, Judith McCaffrey, et al.
Cancer Investigation|January 12, 2005
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology GroupCorey J Langer, Yi Li, Timothy Jennings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology GroupMichael K Gibson, Yi Li, Barbara Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational studyAdil Daud, Nikola Valkov, Barbara Centeno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trialAdil I Daud, Jana Dawson, Ronald C DeConti, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|April 10, 2012
Chemotherapy of squamous cell carcinoma of the skinRonald C DeConti
Seminars in Oncology|April 10, 2012
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinomaSreekanth Donepudi, Ronald C DeConti, Wolfram E Samlowski
Seminars in Oncology|April 10, 2012
Introduction: Advanced cutaneous malignanciesL Frank Glass, Ronald C DeConti, Vernon K Sondak
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Survival after surgical resection of isolated pulmonary metastases from malignant melanomaStephanie Andrews, Lary Robinson, Alan Cantor, et al.
Cancer|January 20, 2011
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, et al.
Head & Neck|March 14, 2014
Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neckTawee Tanvetyanon, Tapan Padhya, Judith McCaffrey, et al.
Cancer Investigation|January 12, 2005
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology GroupCorey J Langer, Yi Li, Timothy Jennings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology GroupMichael K Gibson, Yi Li, Barbara Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational studyAdil Daud, Nikola Valkov, Barbara Centeno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trialAdil I Daud, Jana Dawson, Ronald C DeConti, et al.
Pageof 2